Induced conformational changes upon Cd2+ binding at photosynthetic reaction centers

  1. Hiroshi Ishikita and
  2. Ernst-Walter Knapp*
  1. Institute of Chemistry and Biochemistry, Free University of Berlin, Takustrasse 6, D-14195 Berlin, Germany
  1. Edited by Harry B. Gray, California Institute of Technology, Pasadena, CA, and approved September 22, 2005 (received for review May 9, 2005)

Abstract

Cd2+ binding at the bacterial photosynthetic reaction center (bRC) from Rhodobacter sphaeroides is known to inhibit proton transfer (PT) from bulk solvent to the secondary quinone QB. To elucidate this mechanism, we calculated the pKa for residues along the water channels connecting QB with the stromal side based on the crystal structures of WT-bRC and Cd2+-bound bRC. Upon Cd2+ binding, we observed the release of two protons from His-H126/128 at the Cd2+ binding site and significant pKa shifts for residues along the PT pathways. Remarkably, Asp-L213 near QB, which is proposed to play a significant role in PT, resulted in a decrease in pKa upon Cd2+ binding. The direct electrostatic influence of the Cd2+-positive charge on these pKa shifts was small. Instead, conformational changes of amino acid side chains induced electrostatically by Cd2+ binding were the main mechanism for these pKa shifts. The long-range electrostatic influence over ≈12 Å between Cd2+ and Asp-L213 is likely to originate from a set of Cd2+-induced successive reorientations of side chains (Asp-H124, His-H126, His-H128, Asp-H170, Glu-H173, Asp-M17, and Asp-L210), which propagate along the PT pathways as a “domino” effect.

The primary electron transfer (ET) event in bacterial photosynthetic reaction center (bRC) is a charge-separation process, which occurs after electronic excitation at the bacteriochlorophyll a (BChla) dimer, the special pair. As a result, the special pair becomes oxidized, while an electron is transferred along the A-branch cofactors from an accessory BChla via bacteriopheophytin to ubiquinone QA in the A-branch and subsequently to QB in the B-branch. After the first ET process, Formula is protonated to QBH and stabilized by a second ET and proton transfer (PT) event, which results in the formation of the doubly protonated dihydroquinone QBH2. The coupled ET/PT reactions involving QA/B in bRC proceed in two phases, as shown by the following reaction schemes (reviewed in refs. 1 and 2):

Kinetic phase 1, overall measurable rate Formula, Formula Formula Kinetic phase 2, overall measurable rate Formula, Formula Formula The PT to Glu-L212 near QB is a prerequisite for the first ET event belonging to kinetic phase 1 (Eq. 1b). In WT-bRC, the rate Formula of this kinetic phase (Eqs. 1a and 1b) is independent of the ET driving force (i.e., the QA/B redox potential difference). The PT rate constant belonging to kinetic phase 1 of WT-bRC was estimated to be 105 s–1 (3). It was suggested that the ET corresponding to kinetic phase 1 is coupled to a “conformational gating” step governed by protein dynamics, which constitutes the rate-limiting step for Formula (4). The second ET event corresponding to kinetic phase 2 (Eq. 2b) is coupled to a PT forming QBH from Formula (Eq. 2a). This PT is govern by a rate constant of 2 × 104 s–1 (3). In contrast to the first ET process, the rate for the second ET process depends on the driving force, which indicates that this ET (Eq. 2b) is the rate-limiting step in kinetic phase 2.

Seven residues, namely His-H126, His-H128, Asp-M17, Asp-L210, Glu-L212, Asp-L213, and Ser-L223, were suggested to be involved in these PT events in WT-bRC (Fig. 1a and reviewed in refs. 1 and 2). The single point mutation of Asp-L213 to Asn(D(L213)N) decreases Formula by a factor of 10, which implies that in kinetic phase 1 the PT to Glu-L212 (Eq. 1a) is less efficient than in WT-bRC (5, 6). In the same mutant a dramatic 6,000-fold decrease of Formula was observed, rendering this rate independent of the ET driving force. This result indicates that in the D(L213)N mutant bRC the PT for kinetic phase 2 (Eq. 2a) becomes rate-limiting in contrast to WT-bRC (5, 6). The inhibition of PT in kinetic phase 2 observed in the D(L213)N single mutant bRC can be removed by the additional mutations Arg-M233 to Cys or Arg-H177 to His. These double mutants D(L213)N/R(M233)C or D(L213)N/R(H177)H are therefore called revertant mutants (2, 6). Based on the structural changes near Glu-H173 observed in the revertant mutant bRC, the proposed mechanism to recover PT involves participation of Glu-H173 in the PT pathway (2, 8, 9).

Fig. 1.

Arrangement of residues at QB binding site. (a) Rearrangement of side chains upon Cd2+ binding along the PT pathways of bRC. Residues from the Cd-bRC structure (PDB ID code 1DV3) (15) or the WT-bRC structure (PDB ID code 1AIG) (20) are colored in CPK atom colors (red for oxygen and blue for nitrogen) or cyan, respectively. (b) The corresponding region in PSII (PDB ID code 1S5L) (47).


The addition of Cd2+ (or Zn2+) ions diminishes Formula and Formula 10- and 20-fold, respectively (1014). Furthermore, in these metal-bound bRCs Formula of kinetic phase 2 becomes independent of the ET driving force, switching the rate-limiting step from ET (Eq. 2b) to PT (Eq. 2a) events [i.e., Formula essentially equals the PT rate, implying a reduction of the PT rate by >102 (11, 12)]. The refinement of the crystal structures for Cd2+/Zn2+-bound bRC confirm that these metal ions bind at Asp-H124, His-H126, and His-H128 (15), although a recent x-ray absorption fine structure spectroscopy study implied a second potential binding site for Zn2+ (16). The double mutation of His-H126 and His-H128 to Ala resulted in a decrease of Formula and Formula by 10- and 4-fold, respectively, giving rise to PT as the rate-limiting process of kinetic phase 2 (17).

The exact mechanism of PT inhibition by metal binding is a matter of debate. Mainly, three mechanisms have been proposed. Cd2+ binding induces (i) inhibition of conformational gating for ET from QA to QB, i.e., Eq. 1b (10) (gating inhibition mechanism), (ii) blocking the ability of the residues at the proton entry point (His-H126/128) to vary their protonation states as proton donor/acceptor groups (17, 18) (His-entry inhibition mechanism), or (iii) pKa shifts of residues in the PT pathways (14) (pKa inhibition mechanism).

Based on the decrease in Formula upon Zn2+ binding Utschig et al. (10) proposed a gating inhibition mechanism, mainly because in WT-bRC the rate-limiting step in kinetic phase 1 was suggested to be the conformational gating step (Eq. 1b) (4). However, more recent studies of the E(L212)N mutant by Ädelroth et al. (13) indicated that the inhibiting step in kinetic phase 1 of Cd2+-bound bRC (Cd-bRC) is PT to Glu-L212 (Eq. 1a) rather than the conformational gating step. Instead of gating inhibition the His-entry inhibition was proposed as the key inhibition mechanism (17, 18). This mechanism is consistent with the location of the Cd2+/Zn2+ binding site at His-H126/128 in the crystal structure of metal-bound bRC (15) and a significant decrease of Formula and Formula by 10- and 4-fold, respectively, in the double mutant H(H126)A/H(H128)A (17). Nevertheless, the decrease of Formula is smaller in this double mutant bRC than the 20-fold decrease observed upon Cd2+ binding (11, 12) (see discussion in ref. 19). Therefore, Gerencsér and Maróti (14) proposed that, instead of the His-entry inhibition mechanism, the PT inhibition by the metal binding is caused by induced pKa shifts of residues along the PT pathways (14). However, this pKa inhibition mechanism may be in contradiction to the essentially unaffected rate of Formula charge recombination in the metal-bound bRC, which is assumed to be sensitive to pKa changes of titratable residues in the PT pathways (discussed in ref. 17). Nevertheless, it should be emphasized that the proposed mechanisms of PT inhibition are not mutually exclusive but point to the dominant effect. In the present study, we calculated the protonation pattern of titratable residues in Cd-bRC based on the crystal structure (15) and report pKa shifts upon Cd2+ binding.

Computational Procedures

Atomic Coordinates. We used crystal structures of the bRC from Rhodobacter sphaeroides for WT-bRC [Protein Data Bank (PDB) ID code 1AIG] (20) and Cd-bRC (PDB ID code 1DV3) (15), obtained under illumination (light-exposed structure), and D(L213)N single mutant with QB at the proximal binding position with respect to the nonheme Fe (PDB ID code 1RY5) (8). Atomic coordinates were obtained in the same way as in previous applications (9, 2123). The positions of hydrogen atoms were energetically optimized with charmm (24) by using the charmm22 force field. During this procedure, the positions of all nonhydrogen atoms were fixed, and all titratable groups were kept in their standard charge state, i.e., basic groups including histidine were considered to be protonated and acidic groups to be ionized. The coordinates of all atoms available in the crystal structure were not optimized.

For both WT-bRC and Cd-bRC, there are also crystal structures available that were obtained under dark conditions (dark-adapted structures PDB ID codes 1AIJ and 1DV6, respectively) (15, 20). The light-exposed and dark-adapted structures were suggested to refer to charge separated Formula and ground PQAQB states, respectively (20). The most remarkable difference among them is the position of QB, being at the proximal binding site in the former and the distal one in the latter with respect to the nonheme iron. Therefore, it was formerly proposed that the movement of QB from the distal site to the proximal site upon formation of the Formula state is prerequisite for ET from Formula to QB (20). However, the functional relevance of the QB movement is still a matter of debate. In recent Fourier transform IR studies, no QB movement was found. Hence, both QB and Formula seem to be located at the proximal site (2527). Furthermore, a time-resolved crystallographic study resulted in no quinone motion upon illumination and indicated that QB binds only in the proximal binding site (28). Mainly because of these experimental results that question the physiologically relevance of the QB distal position, we prefer the light-exposed structures to describe the PQAQB and Formula states and use them consistently in the present study.

Atomic Charges. Atomic partial charges of the amino acids were adopted from the all-atom charmm22 (24) parameter set. For cofactors and residues whose charges are not available in charmm22, we used atomic partial charges from previous applications (2123). For the atomic charges for the Cd2+–protein complex in Cd-bRC, see Supporting Text and Table 3, which are published as supporting information on the PNAS web site.

Computation of Protonation Pattern and pKa. The computation of the energetics of the protonation pattern is based on the electrostatic continuum model, in which the linearized Poisson Boltzmann equation is solved by the program mead from Bashford and Karplus (29). To sample the ensemble of protonation patterns by a Monte Carlo method, we used our own program karlsberg (http://agknapp.chemie.fu-berlin.de/karlsberg). The dielectric constant was set to εP = 4 inside the protein and εW = 80 for solvent and protein cavities corresponding to water (see Supporting Text). All computations were performed at 300 K, pH 7.0, and an ionic strength of 100 mM. The linearized Poisson Boltzmann equation was solved by a three-step grid-focusing procedure with a starting grid resolution of 2.5 Å, an intermediate grid resolution of 1.0 Å, and a final grid resolution of 0.3 Å. Monte Carlo sampling yields the probabilities [A ] and [AH] of the deprotonated and protonated state of the titratable residue A, respectively. With the Henderson–Hasselbalch equation, the pKa can be calculated as the pH where the concentration of [A ] and [AH] are equal. The protonation patterns were computed for the Formula redox state, if not otherwise stated. The procedures to obtain pKa of titratable residues are equivalent to those of the redox potential for redox-active groups, although in the latter case the Nernst equation is applied (31). Therefore, the accuracy of the present pKa computations is directly comparable to that obtained for recent computations on redoxactive cofactors (2123). From the analogy, the numerical error of the pKa computation can be estimated to be ≈0.2 pH units. Systematic errors, which typically relate to specific conformations that may differ from the given crystal structures, can sometimes be considerably larger. Because the present study was done under the same conditions as our previous pKa computation for bRC, further details on error estimates and comparisons with the previous results can be obtained in ref. 9.

Results and Discussion

Protonation Pattern Coupled to PT in Kinetic Phase 1 and 2. To study PT inhibition in bRC upon Cd2+ binding, we calculated the protonation pattern of titratable residues coupling to the following charge states: (i) Formula and Formula for PT in kinetic phase 1 (Eq. 1a) and (ii) Formula and Formula for PT in kinetic phase 2 (Eq. 2a). With the electrostatic method used in the present study we can evaluate energetic differences in protonation states between initial states before PT and the corresponding final states, while ignoring activation barriers. In WT-bRC, both PT events considered here, the one to Glu-L212 belonging to kinetic phase 1 and the one Formula belonging to kinetic phase 2, did not result in essential changes of protonation pattern (Table 1). This finding contrasts with the PT to Glu-L212 in Cd-bRC, which is accompanied by deprotonation of Asp-L213 by 0.74 H+ and Glu-M236 by 0.37 H+. Astonishingly, even after removing Cd2+ in the Cd-bRC structure, the same amount of deprotonation for these two residues was obtained (Table 1), which indicates that the Cd2+ ionic effect on the protonation pattern is small (see Main Electrostatic Effects of Cd2+ Binding). These results imply that to protonate Glu-L212 during kinetic phase 1 Cd-bRC requires an additional energy to deprotonate Asp-L213 and Glu-M236, which is not needed in the corresponding PT in WT-bRC. Deprotonation of Asp-L213 (by 0.89 H+) was also observed for PT to Formula in Cd-bRC belonging to kinetic phase 2, although the protonation state of Glu-M236 remained unchanged (Table 1).

View this table:
Table 1. Protonation state coupled to PT in kinetic phase 1 and 2 in elementary charge units

It is known that mutation of Asp-L213 to Asn in bRC inhibits PT events more drastically [Formula and Formula decrease by a factor of 10 and 6,000, respectively] than Cd2+ binding, resulting in a photosynthetically incompetent bRC (5, 6). The calculated protonation pattern for the D(L213)N mutant showed deprotonation of Glu-M236 by 0.57 H+ or 0.10 H+ to yield PT to Glu-L212 or to Formula, respectively (Table 1). These observed deprotonations of Glu-M236 in the D(L213)N mutant were larger than those computed for Cd-bRC (Table 1). We assume that in vivo the corresponding deprotonation requires considerable energy, which consequently might prevent deprotonation. We interpret deprotonation of these residues as their “resistance” to PT. The computational results in the present study imply energetically unfavorable conditions for PT involving Asp-L213 or Glu-M236 in these PT-inhibited bRCs [Cd-bRC and D(L213)N mutant bRC].

Proton Release from His-H126 and His-H128 upon Cd2+ Binding. The crystal structure of Cd-bRC revealed the Cd2+ binding site, which consists of Asp-H124, His-H126, and His-H128 (11, 15). Based on the measurement for the dissociation constant of Cd2+, Paddock et al. (18) suggested that below pH 6.0 two protons (2 H+) were released upon binding of Cd2+ from His-H126 and His-H128. This result is comparable to the proton release by 1.5 H+ at pH 6.5 upon Ni2+ binding studied by Gerencsér and Maróti (14). Based on the WT-bRC structure we computed the protonation of His-H126 and His-H128 to be 0.9 and 0.9 H+, respectively, at pH 6.0 in the QAQB state. Removing Cd2+ from the Cd-bRC structure, we obtained under the same conditions practically the same protonation, namely 0.9 and 0.8 H+ for His-H126 and His-H128, respectively. If Cd2+ binds at these two histidines, these protons will be released, which corroborates the experimentally observed proton release of 1.5–2 H+ at pH ≈6. Indeed, His-H126 and His-H128 are the residues that changed their protonation states most dramatically upon Cd2+ deletion for Cd-bRC in the present study.

PT Pathways: pKa Decrease upon Cd2+ Binding. It is commonly accepted that Cd2+ binding has little impact on the charge recombination rate of Formula despite the positive Cd2+ charge near QB (10, 11, 13, 14). To elucidate the electrostatic influence of Cd2+ binding on residues involved in PT events, we calculated the pKa for those residues along the PT pathways for the Formula charge state. With Cd2+ binding at bRC, several acidic residues in the PT pathway showed significant decrease in pKa by up to 3.9 units: for instance, 1.1, 1.3, 1.5, 1.8, 2.5, and 3.9 units for Glu-H230, Asp-L213, Asp-M17, Glu-M236, Asp-H170, and Asp-H119, respectively (Table 2).

View this table:
Table 2. pKa of acidic residues in the QAQB- state

These residues are of interest for two reasons. First, most of these residues are those that experience pKa increases upon revertant mutations in bRC (9). The recovery of PT in revertant mutant bRC suggests that an alternative PT pathway involving Glu-H173 is operative in this case (2, 8, 9, 32). In comparison with WT-bRC (20), both Cd-bRC (15) and revertant mutant bRC (8) revealed significant structural changes at Glu-H173 and the near surroundings, which seemingly relates to variation in the activity of an additional PT pathway (i.e., being inhibited in WT-bRC and operative in both Cd-bRC and revertant mutant bRC). The present study suggests that residues affected by revertant mutants or Cd2+ binding are closely associated with each other, which points to the importance of these residues for the revertant mutant bRC, as proposed in a previous study (9).

Second, Gerencsér and Maróti (14) observed that Formula, the rate of kinetic phase 1 [Formula], is constant at low pH but starts to decrease above a critical pH value. This effect occurs at pH 9.2 in WT-bRC and is thus connected to a moiety of titratable residues with corresponding apparent pKa, which was down-shifted by 1.8 pH units to 7.4 in Cd-bRC. On the other hand, we calculated a pKa of 8.9 and 7.6 for Asp-L213 in WT-bRC and in Cd-bRC, respectively (Table 2). Taking into account the experimental evidence for the importance of Asp-L213 in PT (reviewed in ref. 1), we tentatively conclude that one of the main titratable groups observed in the study of Gerencsér and Maróti (14) is Asp-L213.

Identification of the Formula-related pKa is still an open question. The measured pH limit, above which Formula starts to decrease, varies slightly with the experimental conditions used by Paddock et al. (33), Gerencsér and Maróti (14), or Takahashi and Wraight (34), being 8.5, 9.2, and 9.5, respectively. From the midpoint of the pH-dependent region, Paddock et al. (33) deduced an apparent pKa value of 9.5 related to Formula. On the other hand, Takahashi and Wraight (34) obtained two pKa values, 9.5 and 11, which they deduced from both edges of the pH-dependent region and assigned to QB and Formula, respectively. In the present study, we determine pKa values at the protonation midpoint of a titratable group, which might be more related to the determination of the pKa used by Paddock et al. (33). Mainly by mutational studies for either E(L212)Q or D(L213)N bRC, this apparent pKa was believed to refer to Glu-L212 as a single residue (33, 34). The calculated pKa values for Glu-L212 are 6.1 for QB and 9.4 for Formula, indicating a proton uptake of this residue at pH 7, as observed in IR (35) and Fourier transform IR (36) studies. Nevertheless, the assignment of Glu-L212 alone to the apparent pKa seems oversimplified, because QB is located in a region of strongly interacting titratable residues. The bRC of the revertant mutant E(L212)A/D(L213)A/R(M231)L from Rhodobacter capsulatus lacks the acidic residue Glu-L212. Nevertheless, the same pH dependence was observed (7, 37), implying that Glu-L212 cannot be the only residue determining the apparent pKa for Formula (14, 38, 39). Indeed, if the two pKa values of 9.5 and 11 for QB and Formula, respectively, were assigned just to Glu-L212 (34), a straightforward interpretation leads to the conclusion that this residue is not involved in proton uptake upon formation of the Formula state at pH 7, which is in conflict with the stoichiometry of proton uptake observed in IR (35) and Fourier transform IR (36) studies and our calculated pKa. Hence, a cluster of strongly interacting titratable residues near QB hinders a clear assignment of this apparent pKa to a specific residue (discussed in refs. 14, 35, 38, and 39). Consistently, recent FTIR studies for E(L212)D/D(L213)E double mutant bRC also demonstrated a strong interaction between carboxylic acids specifically in the QB region, which cannot be interpreted with a simple, conservative concept of amino acid replacement effect between Glu and Asp (40). More recently, electron nuclear double resonance studies suggested a significant role of Asp-L213 in the rate-limiting step for kinetic phase 1 [Formula] by rotating the hydroxyl group of Ser-L223 to Formula, as predicted in electrostatic computations (22, 42). Unlike Glu-L212, Asp-L213 is generally considered not to be involved in proton uptake upon formation of the Formula state, but this idea does not imply that Asp-L213 cannot participate in PT (reviewed in ref. 1).

We conclude that Asp-L213 is one of the main contributors to the apparent pKa shift for Formula upon Cd2+ binding, without excluding a substantial contribution of nearby interacting residues such as Glu-L212 or Asp-M17. This finding agrees with the deduced conclusion in former studies that not only Glu-L212 but also a cluster of strongly interacting titratable residues contribute to the pH dependence of Formula (14, 38, 39).

Asp-L213, a Residue in PT Pathways. Formerly the decrease of Formula upon Zn2+ binding was interpreted as being caused by the inhibition of the conformational gating step (10). However, more recent kinetic studies suggest that the decrease of Formula upon metal binding (by 10-fold with respect to WT-bRC) is caused by the inhibition of PT to Glu-L212 rather than the conformational gating step (13). An equal amount of reduction in Formula for the D(L213)N mutant was previously attributed to the inhibition of PT to Glu-L212 via Asp-L213 (i.e., proton uptake by Glu-L212 belonging to kinetic phase 1) (5) (see also Fig. 1a for the location of Asp-L213 and Glu-L212). From these experimental observations, we believe that Cd2+ binding inhibits the function of Asp-L213 as PT mediator in kinetic phase 1, which slows down the PT to Glu-L212. Because Asp-L213 is directly involved in the PT pathway to Q B of kinetic phase 2, the inhibition of Asp-L213 function in PT should also reduce Formula dramatically, thus changing the energetics of kinetic phase 2 from a ET driving force-dependent to driving force-independent reaction. The calculated pKa down-shift of 1.5 for Asp-M17 upon Cd2+ binding (Table 2) may also partially contribute to the inhibition of PT to Formula in kinetic phase 2. However, the influence of Asp-M17 on the PT rates is suggested to be smaller [only 2-fold decrease in Formula upon the mutation from Asp-M17 to Asn], i.e., ET is still the rate-limiting step (12).

The drastic 10-fold decrease in Formula and 6,000-fold decrease in Formula upon mutation from Asp-L213 to Asn indicates the importance of the role of Asp-L213 in efficient PT events of WT-bRC (5, 6). In turn, this large impact of Asp-L213 on PT events implies already that, even in WT-bRC, only a small perturbation of this residue might result in serious retardation of the PT for both kinetic phases. Thus, we interpret the decrease in pKa for Asp-L213 upon Cd2+ binding in the present study as being one of the important factors of the mechanism of PT inhibition. On the other hand, the distance between Cd2+ and Asp-L213 is ≈12 Å, which may be too large for a significant direct electrostatic interaction (Cd2+ ionic effect) (see Main Electrostatic Effects of Cd2+ Binding).

Remarkably, similar long-range electrostatic interactions were formerly proposed by Sebban et al. (39) with their study of the revertant mutant bRC from R. capsulatus, which possesses Arg-M231 and Asn-M43 at distances of 9 and 15 Å from QB, respectively. Each single mutation of Arg-M231 to Leu or Asn-M43 to Asp shifted the pKa of titratable residues with respect to WT-bRC and resulted in a similar level of electrostatic influence on QB. They interpreted these long-range electrostatic influences as the consequence of a rearrangement of a combined salt-bridge/H-bond network propagated between the mutation site and QB, as an electrostatic domino effect (39). The comparison of the side-chain orientation in the crystal structures between Cd-bRC and WT-bRC clearly indicates the electrostatic domino effect among a number of residues along the water channels to QB (Fig. 1a). The side-chain reorientation of Asp-L213 upon Cd2+ binding is likely to propagate via Asp-H124, His-H126, His-H128, Asp-H170, Glu-H173, Asp-L210, and Asp-M17 (Fig. 1a). The majority of these residues were proposed to participate in the main PT pathway (1) to Glu-L212 or QB. These rearrangements of side chains are accompanied by displacement of crystal water molecules, which can be clearly seen near those residues participating in an H-bond network involving Asp-H124, His-H126, His-H128, Glu-H173, Asp-L210, Glu-L212, and Asp-M17 (Fig. 2, which is published as supporting information on the PNAS web site). The absence of two crystal water molecules near Glu-M173 in WT-bRC compared with Cd-bRC is probably related to its disordered side chain in the former structure, which is fixed upon Cd2+ binding (discussed in ref. 15). Because of its strong polarization effect, a water molecule is able to stabilize newly oriented side-chain positions efficiently. If there is an H-bond network nearby, such a movement of water molecule leads, in turn, to an immediate rearrangement of the H-bond pattern along this network. Therefore, the electrostatic domino effect can probably occur more preferentially if the residues are located near channel water molecules. We propose an electrostatic influence of Cd2+ binding on PT inhibition as follows. Cd2+ binding causes reorientation of the Cd2+-ligating residues Asp-H124, His-H126, and His-H128, which in turn results in side-chain reorientations of Asp-H170, Asp-M17, Asp-L210, and Glu-H173 mediated by water molecules along the water channel. In this way, rearrangement of the Asp-L213 side-chain can be induced by Cd2+ even at a distance of 12 Å, leading to its pKa shift and inhibition of PT.

Main Electrostatic Effects of Cd2+ Binding. Despite the well known inhibition of PT by Cd2+ binding, the exact mechanism is a matter of debate. In the present study, we observe significant shifts of pKa for residues along the PT pathways of WT-bRC or revertant mutant bRC, which are consistent with a pKa inhibition mechanism (14). But, taking into account current criticisms against the pKa inhibition mechanism (see discussions in ref. 17), we further examined the origin of the pKa shifts obtained in the present study.

Quite generally, pKa shifts of titratable groups in proteins, computed relative to the corresponding model compounds in solution, originate from electrostatic interactions with the protein environment. Cofactors like Cd2+ are part of this environment in the case of Cd-bRC. The total electrostatic interaction of Cd2+ with a titratable residue can be split into (i) the bare influence from the positive charge on Cd2+, which also includes changes in protonation pattern (Cd2+ ionic effect) and (ii) the remaining part, which involves conformational changes induced by Cd2+ binding (the conformation effect). Accordingly, we defined the Cd2+ ionic effect on the pKa of a titratable group as ΔpKa(Cd2+ charge) = pKa(with Cd2+ in the Cd-bRC structure) – pKa(without Cd2+ in the Cd-bRC structure) and the conformation effect as ΔpKa(Cd2+ conformation) = pKa(without Cd2+ in the Cd-bRC structure) – pKa(WT-bRC structure) (Table 2). Notably, the two light-exposed crystal structures of bRC (WT-bRC and Cd-bRC) were obtained in the same laboratory (15, 20). Comparison of the atomic coordinates of the two bRC structures yields a rms difference of 0.65 Å, which is considerably larger than uncertainties in the atomic coordinates (see ref. 15). Therefore, the difference of calculated pKa values for the same residue between the two structures refers directly to their structural differences. One pKa unit, being equal to 60 mV, is the same magnitude as the direct influence of His ligand on E m(Chla) (43), which is sufficiently larger than the error in the present computation.

Evaluating these pKa we conclude that the pKa shifts can predominantly be attributed to conformational changes induced by Cd2+ binding and not by Cd2+ ionic effect (Table 2). In the present study, this conclusion holds true for all residues that showed significant pKa shifts upon Cd2+ binding. Indeed, those residues experiencing pKa shifts upon Cd2+ binding also display considerable rearrangements of their own side chain and nearby surroundings (Fig. 1a).

The direct-charge effect of Cd2+ binding was small and, in most cases, even negligible with respect to the effect caused by conformational changes. It is of interest to understand how the direct-charge influence of the cationic Cd2+ is weakened (Table 2). Asp-L210, located proximal to the Cd2+–protein complex, is the only residue whose pKa is significantly affected (down-shift of 2 units) by the Cd2+ ionic effect (Table 2). However, the pKa of this residue is simultaneously up-shifted by the same amount on account of the conformational change effect, resulting in a vanishing pKa shift. Thus, to resist electrostatic perturbations applied to the protein environment upon Cd2+ binding, some residues are apt to neutralize the Cd2+ ionic effect on their pKa by a conformational change (i.e., conformational change effect). This remarkable compensation of the direct-charge effect of Cd2+ found in the present study is consistent with the small effect on the rate of charge recombination for Formula that is commonly observed with Cd2+ binding (10, 11, 13, 14).

Concluding Remarks

Our results can be summarized as follows: Cd2+ binding induces rearrangements of side chains of titratable groups along the PT pathways, leading to significant pKa shifts. Especially, inhibitions of residues in the immediate vicinity of QB, namely of Asp-L213, are assumed to affect the PT kinetics most dramatically. The electrostatic influence of Cd2+ over a large distance (≈12 Å) can be understood by the electrostatic domino effect (39), in which successive reorientation of residues (Asp-H124, His-H126, His-H128, Asp-H170, Glu-H173, Asp-M17, and Asp-L210) propagate over a large distance. The direct electrostatic influence of the Cd2+ ionic charge on these pKa shifts is small and, in most cases, even negligible. The results of the present study are consistent with the pKa inhibition mechanism (14) and provide theoretical detail for understanding this mechanism.

The present study may also provide a key to understanding the Cd2+ binding effect on the QA/B site in photosystem II (PSII). PSII is an oxygen-evolving protein–pigment complex functioning in cells ranging from cyanobacteria to higher plants. Especially, the D1/D2 protein in PSII resembles considerably subunit L/M in bRC, which suggests that both PSII and bRC derive from a common ancestor (44). It has been proposed that D1-His-252 may be a Cd2+ binding site in PSII (45). In the present study of bRC, the pKa of Asp-L213 was found to decrease upon Cd2+ binding. According to the protein sequence alignment [based on analysis with clustal (46)], Asp-L213 and Ser-L223 in bRC from R. sphaeroides (Fig. 1a) correspond to D1-His-252 and D1-Ser-264 in PSII (Fig. 1b), which suggests their importance in ET and PT to QB. The most significant difference between the two proteins near the QA/B binding site is that PSII lacks a polypeptide corresponding to subunit H in bRC. Thus, Asp-H124, His-H126, and His-H128 of the Cd2+ binding site and Glu-H173 (Fig. 1a), all of which play an important role in the PT events of WT-bRC or PT-revertant mutants, are not conserved in PSII. Therefore, D1-His-252 in PSII, which corresponds to Asp-L213 in bRC, is exposed to solvent (30) and may be the Cd2+ binding site. In our computation we observed significant proton uptake at D1-His-252 upon formation of Formula in PSII (41), which suggests its importance in the coupled ET and PT events of PSII. The conservation of Asp-L213/D2-His-252 seems to be thus important for both QB function and Cd2+ binding in bRC/PSII.

In the present study, we could not directly evaluate the His-entry inhibition mechanism for Cd2+ binding (17, 18), partly because of the unavailability of the crystal structure for the H(H126)A/H(H128)A double mutant. Thus, it remains unclear whether this double mutant is PT-inhibited by disabling His-H126/128 as a proton entry point or whether it also supports an electrostatic domino effect by removal of protonated His-H126/128. The decrease of Formula and Formula by 10- and 4-fold, respectively, in the double mutant H(H126)A/H(H128)A relative to WT-bRC (17) undoubtedly indicates their importance in the PT events. Nevertheless, that the 4-fold decrease in Formula for this double mutant is still smaller than the 20-fold reduction of Formula upon Cd2+ binding (11, 12) implies the presence of a missing link between the His-entry inhibition mechanism and the actual mechanism for PT inhibition by Cd2+ binding. This discrepancy might, however, be interpreted as a possible weaker electrostatic domino effect in the double mutant compared with Cd-bRC. We do not exclude a potential contribution of the proposed delocalized PT network (7, 14, 37) to the overall PT events, although we assume that the main PT pathway probably proceeds from the Cd2+ binding site of His-H126/128 (18). In fact, the majority of residues belonging to delocalized PT network in bRC whose pKa were affected by the revertant mutants (9) are in common with those influenced by Cd2+ binding.

Acknowledgments

We thank Dr. Donald Bashford (The Scripps Research Institute, La Jolla, CA) and Dr. Martin Karplus (Harvard University, Boston) for providing the programs mead and charmm22, respectively, and Dr. Dennis Diestler (University of Nebraska, Lincoln) for careful reading of the manuscript. This work was supported by Deutsche Forschungsge-meinschaft Collaborative Research Center SFB 498, Projects A5, Forschergruppe Project KN 329/5-1/5-2, and Collaborative Research Center Grants GRK 80/2, GRK 268, and GRK 788/1. H.I. was supported by the Deutscher Akademischer Austauschdienst.

Footnotes

  • * To whom correspondence should be addressed. E-mail: knapp{at}chemie.fu-berlin.de.

  • Author contributions: E.-W.K. designed research; H.I. performed research; H.I. and E.-W.K. analyzed data; and H.I. and E.-W.K. wrote the paper.

  • Conflict of interest statement: No conflicts declared.

  • This paper was submitted directly (Track II) to the PNAS office.

  • Abbreviations: bRC, bacterial photosynthetic reaction center; Cd-bRC, Cd2+-bound bRC; ET, electron transfer; PDB, Protein Data Bank; PSII, photosystem II; PT, proton transfer.

  • Paddock, M. L., Flores, M., Isaacson, R., Chang, C., Selvaduray, P., Feher, G. & Okamura, M. Y. (2005) Biophys. J. 88, 204 A (abstr.).

References